{"gene":"FOXL2","run_date":"2026-04-28T17:46:04","timeline":{"discoveries":[{"year":2004,"finding":"Murine Foxl2 is required for granulosa cell differentiation (squamous-to-cuboidal transition) and ovary maintenance; loss of Foxl2 leads to absence of secondary follicles, oocyte atresia, and loss of activin-betaA and AMH expression, while causing premature activation of primordial follicles","method":"Foxl2(lacZ) homozygous knockout mouse model with histological analysis, gene expression studies","journal":"Development","confidence":"High","confidence_rationale":"Tier 2 — clean KO with defined cellular and molecular phenotypes, replicated across labs","pmids":["14736745"],"is_preprint":false},{"year":2007,"finding":"Combined inactivation of Wnt4 and Foxl2 in XX mice produces full female-to-male sex reversal including testis tubule formation and spermatogonia; forced expression of Foxl2 impairs testis tubule differentiation in XY transgenic mice, demonstrating an anti-testis role for Foxl2","method":"Double knockout mouse genetics, transgenic overexpression, histological analysis","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis with orthogonal gain- and loss-of-function experiments","pmids":["17728319"],"is_preprint":false},{"year":2004,"finding":"Polyalanine expansion mutations in FOXL2 (14 to 24 alanines) cause extensive intranuclear aggregation and cytoplasmic mislocalisation of the protein; wild-type and mutant proteins can co-aggregate, suggesting a dominant-negative mechanism via sequestration","method":"Transfection of GFP-fusion constructs in COS-7 cells, immunofluorescence","journal":"Journal of medical genetics","confidence":"Medium","confidence_rationale":"Tier 3 — single lab, transfection with fluorescence imaging, moderate follow-up","pmids":["15591279"],"is_preprint":false},{"year":2006,"finding":"FOXL2 is expressed in pituitary gonadotropes and thyrotropes co-localizing with the glycoprotein hormone alpha-subunit (αGSU/Cga); FOXL2 regulates Cga transcription in gonadotrope-derived cells in a context-dependent manner, and a FOXL2-VP16 fusion drives ectopic Cga expression in transgenic animals; FOXL2 expression requires Lhx3 and Lhx4","method":"Immunofluorescence co-localization, reporter assays in multiple cell lines, transgenic mice, epistasis analysis","journal":"Molecular endocrinology","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (reporter assay, transgenic rescue, co-localization, genetic epistasis)","pmids":["16840539"],"is_preprint":false},{"year":2008,"finding":"FoxL2 binds a forkhead-binding element (FKHB) adjacent to a Smad-binding element (SBE1) in the follistatin gene intron, directly associates with Smad3 (but not Smad2 or Smad4) via Smad3's MH2 domain in an interaction requiring an intact FoxL2 forkhead domain, and functions as a Smad3 partner to drive SBE1-mediated follistatin transcription in activin-treated gonadotrope cells","method":"Proteomics/co-IP identification, reporter assays, ChIP, shRNA knockdown, domain-mapping co-IP","journal":"Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 — multiple orthogonal methods: ChIP, reciprocal co-IP, domain mutagenesis, reporter assays, knockdown","pmids":["19106105"],"is_preprint":false},{"year":2010,"finding":"FOXL2 physically interacts with steroidogenic factor-1 (SF-1) in granulosa cells (identified by yeast two-hybrid and confirmed by co-IP), and represses SF-1-induced CYP17 transcription by inhibiting SF-1 binding to the CYP17 promoter; BPES-associated FOXL2 mutants lose this repressive activity","method":"Yeast two-hybrid screen, co-IP in human granulosa cells, ChIP, EMSA, reporter assays, BPES mutant analysis","journal":"Molecular endocrinology","confidence":"High","confidence_rationale":"Tier 1–2 — multiple orthogonal methods confirming physical interaction and functional consequence","pmids":["20207836"],"is_preprint":false},{"year":2010,"finding":"The FOXL2 p.C134W (c.402C>G) tumor-associated mutation does not strongly alter subcellular localization, solubility, or transactivation on most target promoters compared to wild-type, but does exhibit altered activity on an artificial promoter co-regulated by FOXL2 and Smad3, suggesting a subtle modification of FOXL2–Smad3 interaction; 3D structural modeling indicates homodimer formation may be disturbed","method":"Subcellular localization studies, transactivation assays on multiple promoters, FRAP, 3D structural modeling","journal":"PLoS one","confidence":"Medium","confidence_rationale":"Tier 2–3 — multiple functional assays but mainly rules out strong effects; structural model is computational","pmids":["20098707"],"is_preprint":false},{"year":2011,"finding":"FOXL2 upregulation promotes G1 cell-cycle arrest, protects granulosa cells from oxidative damage by promoting oxidized DNA repair and increasing glutathione, and modulates cell-cycle regulator expression; the SIRT1 deacetylase suppresses FOXL2 activity on cell-cycle and DNA repair targets in a dose-dependent manner","method":"Functional genomics, cell-cycle analysis (FACS), oxidative stress assays, deacetylase inhibitor experiments, comparison of BPES mutation classes","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal assays including cell biology, pharmacological intervention, and mutation-class comparison","pmids":["21289058"],"is_preprint":false},{"year":2011,"finding":"In Foxl2 mutant mouse pituitaries, gonadotrope specification is normal but FSHβ expression is severely impaired; activin-induced FSHβ expression and FSH secretion are abolished in primary pituitary cultures from Foxl2 mutant mice, demonstrating that FoxL2 is required for the activin-dependent activation of Fshb transcription","method":"Foxl2 mutant mouse analysis, primary pituitary cell cultures, hormone measurement, RT-PCR","journal":"Molecular endocrinology","confidence":"High","confidence_rationale":"Tier 2 — in vivo KO combined with primary culture mechanistic validation","pmids":["21700720"],"is_preprint":false},{"year":2011,"finding":"FOXL2 synergizes with SMAD2, SMAD3, and SMAD4 to stimulate murine Fshb promoter activity; SMAD3-induced Fshb expression depends on endogenous FOXL2; both FOXL2 and SMAD3/4 must bind DNA at adjacent cis-elements (proximal FKH element and SMAD-binding element) for full activin induction of Fshb transcription","method":"Reporter assays in heterologous and homologous cells, site-directed mutagenesis of promoter elements, FOXL2-SMAD interaction studies","journal":"Molecular endocrinology","confidence":"High","confidence_rationale":"Tier 2 — epistasis by promoter mutagenesis combined with co-transfection and endogenous knockdown","pmids":["21622537"],"is_preprint":false},{"year":2009,"finding":"In Foxl2-null mice, early testis genes (Inhbb, Dhh, Sox9) are upregulated and several novel ovarian genes are dysregulated during embryonic development; gene-dosage sensitivity is demonstrated by heterozygous Foxl2 loss; a Foxl2 transgene disrupts embryonic testis differentiation and upregulates female markers, supporting dose-dependent anti-testis action throughout ovary differentiation","method":"Transcriptome profiling of Foxl2 knockout and double-mutant ovaries, transgenic rescue, principal component analysis","journal":"BMC developmental biology","confidence":"High","confidence_rationale":"Tier 2 — genome-wide expression profiling combined with genetic epistasis and transgenic gain-of-function","pmids":["19538736"],"is_preprint":false},{"year":2014,"finding":"Conditional knockout of Foxl2 in gonadotrope cells causes FSH deficiency, subfertility, and impaired activin-stimulated Fshb expression in primary cultures, establishing FOXL2 as the first gonadotrope-restricted transcription factor required for selective FSH synthesis in vivo","method":"Cre/lox conditional knockout, hormone assays, reproductive phenotyping, primary pituitary cultures","journal":"Molecular endocrinology","confidence":"High","confidence_rationale":"Tier 2 — clean conditional KO with defined endocrine and fertility phenotypes","pmids":["23340250"],"is_preprint":false},{"year":2014,"finding":"Combined conditional deletion of Foxl2 and Smad4 in gonadotropes essentially abolishes FSH synthesis and causes female sterility phenotype comparable to Fshb-knockout mice, establishing SMAD4 and FOXL2 as essential master regulators of Fshb transcription in vivo","method":"Double conditional knockout mouse (Cre/lox), FSH measurement, fertility phenotyping","journal":"FASEB journal","confidence":"High","confidence_rationale":"Tier 2 — double conditional KO with strong phenotypic evidence","pmids":["24739304"],"is_preprint":false},{"year":2014,"finding":"FOXL2 is required for normal gene regulation by steroid receptors in murine primary follicular cells; FOXL2 directly modulates Esr2 (estrogen receptor beta) expression through a newly identified intronic element; FOXL2 represses Sox9 both independently and through activation of ESR2, establishing a coherent feed-forward loop for ovarian maintenance","method":"Primary follicular cell isolation, ChIP-seq, reporter assays, loss-of-function analysis","journal":"eLife","confidence":"High","confidence_rationale":"Tier 2 — ChIP with functional validation in primary cells and KO model","pmids":["25369636"],"is_preprint":false},{"year":2014,"finding":"FOXL2 directly transactivates AMH transcription (confirmed by luciferase assay, EMSA, and ChIP); BPES-associated FOXL2 mutants fail to activate AMH; in vivo, ectopic FOXL2 prevents AMH-knockdown-accelerated follicle growth, demonstrating positive cross-regulation between FOXL2 and AMH in ovarian follicle reserve maintenance","method":"Luciferase reporter assay, EMSA, ChIP, in vivo mouse gene delivery","journal":"Fertility and sterility","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal in vitro and in vivo methods","pmids":["24973035"],"is_preprint":false},{"year":2014,"finding":"FOXL2 transcriptionally represses Sf1 by antagonizing WT1-KTS activation of the Sf1 proximal promoter; a conserved FOXL2 binding site was identified by ChIP; mutations abolishing this site eliminate FOXL2-mediated repression; in Foxl2-null mice, Sf1 expression is increased 2-fold in XX fetal gonads","method":"Reporter assays, ChIP, site-directed mutagenesis, Foxl2-null mouse analysis","journal":"FASEB journal","confidence":"High","confidence_rationale":"Tier 2 — in vitro mechanistic assays confirmed in vivo by KO mouse","pmids":["24451388"],"is_preprint":false},{"year":2014,"finding":"The C134W FOXL2 mutation undergoes differential post-translational modifications compared to wild-type: GSK3β hyperphosphorylates C134W at serine 33, inducing MDM2-mediated ubiquitination and proteasomal degradation; wild-type FOXL2 is underphosphorylated at S33, leading to SUMOylation and stabilization; S33 phosphorylation status correlates with GCT oncogenicity in xenograft mice, and GSK3β inhibition represses GCT growth","method":"In vitro kinase assays, mutagenesis, ubiquitination and SUMOylation assays, xenograft mouse model, patient tissue analysis","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1–2 — reconstituted PTM cascade with in vivo validation in xenograft and patient tissue","pmids":["24390485"],"is_preprint":false},{"year":2005,"finding":"FOXL2 interacts with DP103 (a DEAD-box RNA helicase) and induces apoptosis in CHO cells and rat granulosa cells; DP103 co-expression potentiates FOXL2-induced cell death","method":"Co-immunoprecipitation, overexpression in CHO and granulosa cells, cell viability assays","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 3 — single lab, co-IP plus functional assay","pmids":["16153597"],"is_preprint":false},{"year":2009,"finding":"Foxl2 suppresses ERα-mediated transcription through nonclassical (AP1-tethered) pathways but has no effect on classical ERE-dependent ERα transcription; Foxl2 physically interacts with ERα (co-IP); Foxl2 represses COX2 expression induced by ERα/tamoxifen signaling","method":"Reporter assays (AP1 and ERE), co-IP, expression profiling, western blotting","journal":"Endocrinology","confidence":"Medium","confidence_rationale":"Tier 3 — co-IP plus functional reporters and expression data, single lab","pmids":["19797124"],"is_preprint":false},{"year":2012,"finding":"FOXL2 directly stimulates the clusterin (Clu) gene promoter in pituitary gonadotroph cells; FOXL2 also binds and suppresses the PTTG promoter; together, FOXL2 and Clu restrain pituitary gonadotroph tumor cell proliferation by inducing CDK inhibitors p16 and p27; in vivo, gonadotroph xenografts overexpressing Clu and FOXL2 grow slower","method":"Reporter assays, ChIP (implied by direct stimulation claim), xenograft mouse model, cell proliferation assays","journal":"Molecular endocrinology","confidence":"Medium","confidence_rationale":"Tier 2–3 — reporter assays with in vivo xenograft validation; mechanistic detail moderate","pmids":["23051594"],"is_preprint":false},{"year":2013,"finding":"Wild-type FOXL2 (but not C134W mutant) induces follistatin production in KGN cells, and exogenous follistatin blocks activin A-stimulated cell proliferation; thus wild-type FOXL2 acts as a tumor suppressor by inducing follistatin that antagonizes activin-stimulated granulosa cell proliferation","method":"FOXL2 overexpression, follistatin ELISA/western blotting, exogenous follistatin rescue, KGN cell proliferation assays","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 3 — single lab, overexpression with rescue experiment","pmids":["24332943"],"is_preprint":false},{"year":2012,"finding":"FOXL2 is involved in activin/progestin synergy on the Fshb promoter; FOXL2 physically interacts with progesterone receptor (PR) and SMAD3; multiple Fshb promoter elements binding FOXL2, SMADs, and PR are required for full synergistic response","method":"Reporter assays, co-IP, promoter mutagenesis","journal":"Endocrinology","confidence":"Medium","confidence_rationale":"Tier 2–3 — co-IP and promoter mutagenesis, single lab","pmids":["22294749"],"is_preprint":false},{"year":2018,"finding":"Genome-wide ChIP-seq of FOXL2 in fetal mouse ovaries shows extensive overlap with SOX9 occupancy in the fetal testis; ectopic FOXL2 expression in fetal testis somatic precursors represses Sertoli cell differentiation and causes partial testis-to-ovary sex reversal, demonstrating FOXL2 is sufficient to feminize the gonad","method":"ChIP-seq, gain-of-function transgenic mouse model, transcriptomic analysis","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 — ChIP-seq combined with gain-of-function mouse genetics","pmids":["30212841"],"is_preprint":false},{"year":2019,"finding":"RUNX1 plays complementary/redundant roles with FOXL2 in maintaining fetal granulosa cell identity; combined loss of RUNX1 and FOXL2 results in masculinization of fetal ovaries; ChIP-seq shows RUNX1 occupancy partially overlaps with FOXL2 occupancy in fetal ovary, suggesting co-regulation of common gene targets","method":"Double conditional knockout mouse, ChIP-seq, single-cell transcriptomics","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 — double KO epistasis combined with ChIP-seq chromatin-level evidence","pmids":["31712577"],"is_preprint":false},{"year":2020,"finding":"The FOXL2 C134W mutant acquires the ability to bind SMAD4, forming a novel FOXL2C134W/SMAD4/SMAD2/3 complex that binds a hybrid DNA motif (AGHCAHAA) unique to the mutant; this binding induces an enhancer-like chromatin state activating nearby genes associated with EMT; ablation of SMAD4 or SMAD2/3 strongly reduces FOXL2C134W binding at hybrid sites","method":"ChIP-seq, co-IP, CRISPR ablation of SMAD4/SMAD2/3, chromatin state analysis, transcriptomics in primary AGCT","journal":"Cancer research","confidence":"High","confidence_rationale":"Tier 1–2 — multiple orthogonal genome-wide and biochemical methods, replicated in primary tumors","pmids":["32641411"],"is_preprint":false},{"year":2020,"finding":"The FOXL2 C134W mutation alters DNA-binding specificity genome-wide; FOXL2C134W associates with the majority of wild-type FOXL2 binding sites as well as a large set of unique sites; altered binding drives an oncogenic transcriptional program including SLC35F2 upregulation, which increases sensitivity to YM155","method":"ChIP-seq and transcriptome profiling in V5-FOXL2WT vs. V5-FOXL2C134W isogenic inducible cell lines","journal":"Cancer research","confidence":"High","confidence_rationale":"Tier 1–2 — isogenic cell lines with genome-wide ChIP-seq and transcriptomics; functional drug sensitivity validation","pmids":["32641414"],"is_preprint":false},{"year":2020,"finding":"The FOXL2 C134W somatic mutation introduces a target site for miR-1236 in the coding sequence; miR-1236 selectively degrades variant FOXL2 mRNA via a non-canonical miRISC directed by AGO3 and DHX9, causing haploinsufficiency of tumor-suppressor FOXL2 in AGCTs","method":"miRNA target site mutagenesis, AGO3/DHX9 co-IP, miR-1236 gain/loss-of-function, patient sample correlation, mouse AGCT model","journal":"EMBO journal","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods including biochemistry, genetics and in vivo validation","pmids":["33215742"],"is_preprint":false},{"year":2015,"finding":"Conditional deletion of Foxl2 in the postnatal uterus using Pgr-cre results in infertility, reduced stromal thickness, hypertrophic/disorganized inner myometrial layer, failure of vascular smooth muscle organization, and deregulation of Wnt signaling genes, demonstrating a role for FOXL2 in uterine maturation","method":"Conditional knockout mouse (Pgr-cre; Foxl2flox/flox), histological analysis, gene expression profiling","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 — clean conditional KO with defined structural and molecular phenotypes","pmids":["25687138"],"is_preprint":false},{"year":2018,"finding":"Conditional deletion of both Foxl2 and Smad4 in gonadotrope cells of adult mice (using tamoxifen-inducible Cre) causes profound FSH reduction, arrested ovarian follicle development, and sterility, demonstrating that FOXL2 and SMAD4 are continuously required for FSH synthesis in adult gonadotropes","method":"Tamoxifen-inducible conditional double KO, FSH ELISA, histological analysis of ovaries","journal":"Endocrinology","confidence":"High","confidence_rationale":"Tier 2 — inducible adult-specific KO distinguishing developmental from maintenance roles","pmids":["29800110"],"is_preprint":false},{"year":2015,"finding":"Foxl2-null mice show defects in postnatal growth, embryonic bone and cartilage formation, and down-regulation of the GH/IGF1 axis; FOXL2 is expressed in neural tube epithelium, head mesenchyme, cartilaginous tissue, and hypothalamus during development; FOXL2 and SOX9 act jointly in cartilage development despite being antagonistic in gonadal sex determination","method":"Foxl2 knockout mouse, skeletal staining, immunofluorescence, microarray, RT-qPCR for GH/IGF1 pathway","journal":"BMC developmental biology","confidence":"Medium","confidence_rationale":"Tier 2–3 — KO with skeletal phenotype and expression data, single lab","pmids":["26134413"],"is_preprint":false},{"year":2022,"finding":"Lineage tracing of Foxl2-expressing cells in fetal mouse ovaries reveals that they are multipotent, giving rise not only to granulosa cells but also to theca-interstitial cells (Theca-G) and stromal cells; single-cell RNA-seq shows two FOXL2-positive clusters at P0, one differentiating into granulosa/Theca-G and another into stromal/Theca-S lineages","method":"Genetic lineage tracing (Cre/Rosa reporter), single-cell RNA-seq across developmental time points","journal":"Cell discovery","confidence":"High","confidence_rationale":"Tier 2 — lineage tracing with scRNA-seq provides direct cellular fate mapping","pmids":["36575161"],"is_preprint":false}],"current_model":"FOXL2 is a forkhead transcription factor that acts as a master regulator of ovarian granulosa cell identity: it drives granulosa cell differentiation, represses testis-determining genes (Sox9, Sf1) by binding their promoters and antagonizing WT1/RUNX1, activates ovarian targets (AMH, follistatin, ESR2/estrogen receptor beta, aromatase) via direct DNA binding and cooperative interactions with SMAD2/3/4, PR, and SF-1, and is required in pituitary gonadotropes—together with SMAD4—for activin-stimulated Fshb transcription; post-translational regulation of FOXL2 by GSK3β-mediated phosphorylation, MDM2-mediated ubiquitination, and SIRT1-mediated deacetylation modulates its stability and activity, while the pathognomonic C134W somatic mutation found in virtually all adult-type granulosa cell tumors alters DNA-binding specificity and hijacks SMAD4/SMAD2/3 to engage an oncogenic transcriptional program, and is also selectively degraded by a non-canonical AGO3/DHX9–miR-1236 miRISC complex that causes tumor-suppressor haploinsufficiency."},"narrative":{"teleology":[{"year":2004,"claim":"Establishing FOXL2 as essential for granulosa cell differentiation answered whether this transcription factor was required for ovary formation and folliculogenesis.","evidence":"Foxl2-lacZ homozygous knockout mice showing absence of secondary follicles, loss of squamous-to-cuboidal transition, and loss of AMH/activin-βA expression","pmids":["14736745"],"confidence":"High","gaps":["Downstream direct transcriptional targets not yet mapped genome-wide","Whether FOXL2 functions cell-autonomously in granulosa cells vs. through paracrine effects not resolved"]},{"year":2005,"claim":"Identification of DP103 as a FOXL2 interactor and demonstration of FOXL2-induced apoptosis suggested a pro-apoptotic function beyond transcriptional regulation of differentiation.","evidence":"Co-IP of FOXL2-DP103 and cell viability assays in CHO and rat granulosa cells","pmids":["16153597"],"confidence":"Medium","gaps":["Not independently replicated","Physiological relevance of DP103 interaction in vivo unknown","Mechanism of FOXL2-induced apoptosis not delineated"]},{"year":2006,"claim":"Demonstrating FOXL2 expression and function in pituitary gonadotropes expanded its role beyond the ovary to neuroendocrine regulation of reproduction.","evidence":"Immunofluorescence co-localization with αGSU, reporter assays in gonadotrope cell lines, transgenic FOXL2-VP16 driving ectopic Cga expression","pmids":["16840539"],"confidence":"High","gaps":["Direct DNA-binding sites on Cga not mapped","Relationship to FSH regulation not yet established"]},{"year":2007,"claim":"Genetic epistasis showing that combined Wnt4/Foxl2 loss causes complete female-to-male sex reversal, and that forced FOXL2 impairs testis formation, established FOXL2 as a bona fide anti-testis factor.","evidence":"Double knockout and transgenic overexpression mouse genetics with histological analysis","pmids":["17728319"],"confidence":"High","gaps":["Molecular targets through which FOXL2 antagonizes testis fate not yet identified at chromatin level","Whether FOXL2 and Wnt4 converge on common downstream effectors unknown"]},{"year":2009,"claim":"Identifying FOXL2 as a SMAD3 partner on the follistatin gene intron revealed the mechanistic basis for FOXL2's integration into TGF-β/activin signaling.","evidence":"Reciprocal co-IP, domain mapping, ChIP, and shRNA knockdown in gonadotrope cells","pmids":["19106105"],"confidence":"High","gaps":["Whether FOXL2-SMAD3 interaction extends genome-wide to other activin targets not determined","SMAD4 role in this specific complex unclear"]},{"year":2010,"claim":"Discovery that FOXL2 physically interacts with SF-1 to repress CYP17 transcription established a mechanism for maintaining granulosa (vs. theca/Leydig) steroidogenic identity.","evidence":"Yeast two-hybrid, co-IP in human granulosa cells, ChIP, EMSA, and BPES mutant loss-of-function","pmids":["20207836"],"confidence":"High","gaps":["Other SF-1 target genes co-regulated by FOXL2 not systematically identified","In vivo validation by conditional KO of FOXL2-SF1 interaction not performed"]},{"year":2011,"claim":"Demonstrating that FOXL2 promotes G1 arrest, oxidative stress protection, and DNA repair — modulated by SIRT1 deacetylation — revealed cell-protective functions beyond transcriptional sex determination.","evidence":"FACS cell-cycle analysis, oxidative stress assays, deacetylase inhibitor treatment, BPES mutation-class comparison","pmids":["21289058"],"confidence":"High","gaps":["Specific acetylation sites on FOXL2 targeted by SIRT1 not mapped","In vivo relevance of SIRT1-FOXL2 axis in ovary not tested"]},{"year":2011,"claim":"Showing that Foxl2-mutant pituitaries fail to produce FSH upon activin stimulation, and that FOXL2 cooperates with SMADs at adjacent Fshb promoter elements, established FOXL2 as the first gonadotrope-specific transcription factor required for FSH synthesis.","evidence":"Foxl2 mutant mouse pituitaries, primary pituitary cultures, reporter assays with promoter mutagenesis","pmids":["21700720","21622537"],"confidence":"High","gaps":["Whether FOXL2 is sufficient to confer Fshb expression on non-gonadotrope cells unknown","Chromatin-level occupancy at endogenous Fshb locus not shown"]},{"year":2014,"claim":"A series of conditional knockout and target-gene studies collectively defined FOXL2's direct transcriptional targets (AMH, ESR2, Sf1, Sox9) and the feed-forward logic by which it maintains ovarian identity: FOXL2 activates ESR2, which cooperatively represses Sox9, while FOXL2 directly represses Sf1 by antagonizing WT1.","evidence":"ChIP-seq in primary follicular cells, conditional gonadotrope KOs, reporter assays, EMSA, in vivo gene delivery, double conditional KOs with SMAD4","pmids":["25369636","24451388","24973035","23340250","24739304"],"confidence":"High","gaps":["Full enhancer-level regulatory network connecting FOXL2 to all ovarian identity genes not mapped","How FOXL2 target selection differs between fetal and adult ovary not resolved"]},{"year":2014,"claim":"Elucidation of the GSK3β → S33 phosphorylation → MDM2 ubiquitination cascade for C134W FOXL2 degradation vs. SUMOylation-mediated stabilization of wild-type FOXL2 provided a post-translational mechanism for how the oncogenic mutant is differentially regulated.","evidence":"In vitro kinase assays, ubiquitination/SUMOylation assays, mutagenesis, xenograft model, patient tissue analysis","pmids":["24390485"],"confidence":"High","gaps":["Whether other kinases phosphorylate S33 in vivo","How SUMOylation modulates wild-type FOXL2 transcriptional activity not detailed"]},{"year":2015,"claim":"Conditional uterine deletion revealed FOXL2 functions beyond the ovary and pituitary, being required for uterine stromal and myometrial maturation and Wnt pathway regulation.","evidence":"Pgr-cre conditional KO with histology and expression profiling","pmids":["25687138"],"confidence":"High","gaps":["Direct FOXL2 binding sites in uterine cells not mapped","Whether uterine defects contribute to infertility independently of ovarian failure not distinguished"]},{"year":2018,"claim":"Genome-wide ChIP-seq in fetal ovary showing FOXL2 occupancy extensively overlapping SOX9 sites, combined with gain-of-function feminization of fetal testis, demonstrated that FOXL2 and SOX9 compete at shared regulatory elements to determine gonadal fate.","evidence":"ChIP-seq in fetal ovary, ectopic FOXL2 transgenic testis model, transcriptomics","pmids":["30212841"],"confidence":"High","gaps":["Whether FOXL2 and SOX9 physically compete for DNA occupancy or act through chromatin remodeling intermediaries not distinguished"]},{"year":2019,"claim":"Discovery that RUNX1 acts redundantly with FOXL2 to maintain fetal granulosa identity — with overlapping chromatin occupancy — revealed that ovarian fate maintenance relies on a transcription factor network rather than FOXL2 alone.","evidence":"Double conditional KO causing fetal ovary masculinization, ChIP-seq overlap, single-cell transcriptomics","pmids":["31712577"],"confidence":"High","gaps":["Whether FOXL2 and RUNX1 form a physical complex or act independently at shared sites unknown","Other transcription factors in the network not identified"]},{"year":2020,"claim":"Mechanistic dissection of the C134W mutation showed it acquires neomorphic DNA-binding specificity, forms a novel complex with SMAD4/SMAD2/3 at hybrid motifs to activate an EMT-associated oncogenic program, while simultaneously being selectively degraded by a miR-1236/AGO3/DHX9 non-canonical miRISC to cause haploinsufficiency — together explaining both gain- and loss-of-function oncogenic mechanisms.","evidence":"ChIP-seq in isogenic WT vs. C134W lines and primary AGCT, CRISPR ablation of SMADs, co-IP, miRNA mutagenesis, AGO3/DHX9 co-IP, mouse AGCT model","pmids":["32641411","32641414","33215742"],"confidence":"High","gaps":["Whether pharmacological disruption of the FOXL2C134W-SMAD4 complex is therapeutically viable not tested","How miR-1236 expression is regulated in AGCT unknown","Structural basis of altered C134W DNA-binding specificity not resolved"]},{"year":2022,"claim":"Lineage tracing of FOXL2-expressing cells revealed they are multipotent progenitors giving rise to granulosa, theca-interstitial, and stromal lineages, redefining FOXL2 from a granulosa-specific factor to a marker of a common ovarian somatic progenitor.","evidence":"Cre/Rosa lineage tracing and single-cell RNA-seq across developmental time points","pmids":["36575161"],"confidence":"High","gaps":["Whether FOXL2 is functionally required in theca and stromal differentiation or merely expressed","Signals that direct FOXL2+ progenitors toward different lineages not identified"]},{"year":null,"claim":"Key unresolved questions include the structural basis for C134W neomorphic DNA binding, the full enhancer-level logic by which FOXL2 coordinates with RUNX1 and other factors across ovarian cell types, and whether targeting the FOXL2C134W-SMAD4 axis is therapeutically tractable in granulosa cell tumors.","evidence":"","pmids":[],"confidence":"High","gaps":["No crystal structure of FOXL2 forkhead domain bound to DNA","Therapeutic targeting of FOXL2C134W-SMAD axis untested","Single-cell-resolved FOXL2 function across all ovarian somatic lineages incomplete"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[4,13,14,15,22,24,25]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,3,4,5,9,13,14,15,19,22,24,25]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[2,3,4,13,22,24,25]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[4,9,12,24]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[0,1,10,22,23,30]},{"term_id":"R-HSA-1474165","term_label":"Reproduction","supporting_discovery_ids":[8,11,12,28]}],"complexes":["FOXL2-SMAD3 transcriptional complex","FOXL2-SMAD4-SMAD2/3 complex (C134W-specific)","FOXL2-SF-1 complex"],"partners":["SMAD3","SMAD4","SMAD2","NR5A1","ESR1","PGR","RUNX1","SIRT1"],"other_free_text":[]},"mechanistic_narrative":"FOXL2 is a forkhead-domain transcription factor that serves as a master regulator of female gonadal identity, granulosa cell differentiation, and pituitary FSH synthesis. In the ovary, FOXL2 maintains female fate by directly repressing testis-determining genes (Sox9, Sf1) and activating ovarian targets (AMH, follistatin, ESR2, aromatase) through cooperative DNA binding with SMAD2/3, SMAD4, SF-1, progesterone receptor, and RUNX1 at adjacent forkhead and SMAD binding elements; loss of FOXL2 causes granulosa cell differentiation failure and, together with loss of Wnt4 or RUNX1, leads to female-to-male sex reversal [PMID:14736745, PMID:17728319, PMID:31712577, PMID:25369636, PMID:24451388]. In pituitary gonadotropes, FOXL2 and SMAD4 are jointly essential for activin-stimulated Fshb transcription and FSH secretion, as conditional deletion of either or both abolishes FSH synthesis and causes infertility [PMID:23340250, PMID:24739304, PMID:29800110]. The somatic C134W mutation, which is pathognomonic of adult-type granulosa cell tumors, alters FOXL2 DNA-binding specificity genome-wide and enables formation of a neomorphic FOXL2-SMAD4-SMAD2/3 complex that activates an oncogenic transcriptional program, while also creating a coding-sequence target for miR-1236-mediated selective degradation of the mutant allele via AGO3/DHX9, producing tumor-suppressor haploinsufficiency [PMID:32641411, PMID:32641414, PMID:33215742]."},"prefetch_data":{"uniprot":{"accession":"P58012","full_name":"Forkhead box protein L2","aliases":[],"length_aa":376,"mass_kda":38.8,"function":"Transcriptional regulator. Critical factor essential for ovary differentiation and maintenance, and repression of the genetic program for somatic testis determination. Prevents trans-differentiation of ovary to testis through transcriptional repression of the Sertoli cell-promoting gene SOX9 (By similarity). Has apoptotic activity in ovarian cells. Suppresses ESR1-mediated transcription of PTGS2/COX2 stimulated by tamoxifen (By similarity). Is a regulator of CYP19 expression (By similarity). Participates in SMAD3-dependent transcription of FST via the intronic SMAD-binding element (By similarity). Is a transcriptional repressor of STAR. Activates SIRT1 transcription under cellular stress conditions. Activates transcription of OSR2","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/P58012/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/FOXL2","classification":"Not Classified","n_dependent_lines":115,"n_total_lines":1208,"dependency_fraction":0.09519867549668874},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/FOXL2","total_profiled":1310},"omim":[{"mim_id":"617480","title":"46,XX SEX REVERSAL 4; SRXX4","url":"https://www.omim.org/entry/617480"},{"mim_id":"608996","title":"PREMATURE OVARIAN FAILURE 3; POF3","url":"https://www.omim.org/entry/608996"},{"mim_id":"606168","title":"DEAD-BOX HELICASE 20; DDX20","url":"https://www.omim.org/entry/606168"},{"mim_id":"605810","title":"MITOCHONDRIAL RIBOSOMAL PROTEIN S22; MRPS22","url":"https://www.omim.org/entry/605810"},{"mim_id":"605597","title":"FORKHEAD TRANSCRIPTION FACTOR FOXL2; FOXL2","url":"https://www.omim.org/entry/605597"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"cervix","ntpm":13.7},{"tissue":"fallopian tube","ntpm":13.0},{"tissue":"ovary","ntpm":43.4}],"url":"https://www.proteinatlas.org/search/FOXL2"},"hgnc":{"alias_symbol":["BPES1"],"prev_symbol":["BPES"]},"alphafold":{"accession":"P58012","domains":[{"cath_id":"1.10.10.10","chopping":"58-117_125-135","consensus_level":"high","plddt":93.1139,"start":58,"end":135}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P58012","model_url":"https://alphafold.ebi.ac.uk/files/AF-P58012-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P58012-F1-predicted_aligned_error_v6.png","plddt_mean":60.12},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=FOXL2","jax_strain_url":"https://www.jax.org/strain/search?query=FOXL2"},"sequence":{"accession":"P58012","fasta_url":"https://rest.uniprot.org/uniprotkb/P58012.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P58012/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P58012"}},"corpus_meta":[{"pmid":"19516027","id":"PMC_19516027","title":"Mutation of FOXL2 in granulosa-cell tumors of the ovary.","date":"2009","source":"The New England journal of medicine","url":"https://pubmed.ncbi.nlm.nih.gov/19516027","citation_count":603,"is_preprint":false},{"pmid":"14736745","id":"PMC_14736745","title":"The murine winged-helix transcription factor Foxl2 is required for granulosa cell differentiation and ovary maintenance.","date":"2004","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/14736745","citation_count":579,"is_preprint":false},{"pmid":"17728319","id":"PMC_17728319","title":"Loss of Wnt4 and Foxl2 leads to female-to-male sex reversal extending to germ cells.","date":"2007","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17728319","citation_count":249,"is_preprint":false},{"pmid":"11468277","id":"PMC_11468277","title":"Spectrum of FOXL2 gene mutations in blepharophimosis-ptosis-epicanthus inversus (BPES) families demonstrates a genotype--phenotype correlation.","date":"2001","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11468277","citation_count":213,"is_preprint":false},{"pmid":"20693978","id":"PMC_20693978","title":"The FOXL2 C134W mutation is characteristic of adult granulosa cell tumors of the ovary.","date":"2010","source":"Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc","url":"https://pubmed.ncbi.nlm.nih.gov/20693978","citation_count":187,"is_preprint":false},{"pmid":"21378549","id":"PMC_21378549","title":"FOXL2 is a sensitive and specific marker for sex cord-stromal tumors of the ovary.","date":"2011","source":"The American journal of surgical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/21378549","citation_count":148,"is_preprint":false},{"pmid":"24485832","id":"PMC_24485832","title":"FOXL2 is a female sex-determining gene in the goat.","date":"2014","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/24485832","citation_count":140,"is_preprint":false},{"pmid":"28838139","id":"PMC_28838139","title":"Mutation of foxl2 or cyp19a1a Results in Female to Male Sex Reversal in XX Nile Tilapia.","date":"2017","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/28838139","citation_count":132,"is_preprint":false},{"pmid":"28119367","id":"PMC_28119367","title":"HMGA2-FOXL2 Axis Regulates Metastases and Epithelial-to-Mesenchymal Transition of Chemoresistant Gastric Cancer.","date":"2017","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/28119367","citation_count":130,"is_preprint":false},{"pmid":"16630569","id":"PMC_16630569","title":"Molecular cloning and analysis of gonadal expression of Foxl2 in the medaka, Oryzias latipes.","date":"2006","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/16630569","citation_count":126,"is_preprint":false},{"pmid":"20198651","id":"PMC_20198651","title":"Mutational analysis of FOXL2 codon 134 in granulosa cell tumour of ovary and other human cancers.","date":"2010","source":"The Journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/20198651","citation_count":119,"is_preprint":false},{"pmid":"16840539","id":"PMC_16840539","title":"FOXL2 in the pituitary: molecular, genetic, and developmental analysis.","date":"2006","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/16840539","citation_count":111,"is_preprint":false},{"pmid":"19538736","id":"PMC_19538736","title":"Foxl2 functions in sex determination and histogenesis throughout mouse ovary development.","date":"2009","source":"BMC developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/19538736","citation_count":108,"is_preprint":false},{"pmid":"14684984","id":"PMC_14684984","title":"Structure, evolution and expression of the FOXL2 transcription unit.","date":"2003","source":"Cytogenetic and genome research","url":"https://pubmed.ncbi.nlm.nih.gov/14684984","citation_count":107,"is_preprint":false},{"pmid":"20207836","id":"PMC_20207836","title":"FOXL2 interacts with steroidogenic factor-1 (SF-1) and represses SF-1-induced CYP17 transcription in granulosa cells.","date":"2010","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/20207836","citation_count":102,"is_preprint":false},{"pmid":"15830351","id":"PMC_15830351","title":"Aromatase inhibition reduces expression of FOXL2 in the embryonic chicken ovary.","date":"2005","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/15830351","citation_count":99,"is_preprint":false},{"pmid":"18726931","id":"PMC_18726931","title":"FOXL2 mutations and genomic rearrangements in BPES.","date":"2009","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/18726931","citation_count":97,"is_preprint":false},{"pmid":"18348162","id":"PMC_18348162","title":"FOXL2 and SOX9 as parameters of female and male gonadal differentiation in patients with various forms of disorders of sex development (DSD).","date":"2008","source":"The Journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/18348162","citation_count":97,"is_preprint":false},{"pmid":"19106105","id":"PMC_19106105","title":"FoxL2 and Smad3 coordinately regulate follistatin gene transcription.","date":"2008","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19106105","citation_count":94,"is_preprint":false},{"pmid":"26033501","id":"PMC_26033501","title":"DICER1 and FOXL2 mutations in ovarian sex cord-stromal tumours: a GINECO Group study.","date":"2015","source":"Histopathology","url":"https://pubmed.ncbi.nlm.nih.gov/26033501","citation_count":86,"is_preprint":false},{"pmid":"25369636","id":"PMC_25369636","title":"The transcription factor FOXL2 mobilizes estrogen signaling to maintain the identity of ovarian granulosa cells.","date":"2014","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/25369636","citation_count":86,"is_preprint":false},{"pmid":"21248146","id":"PMC_21248146","title":"Minireview: roles of the forkhead transcription factor FOXL2 in granulosa cell biology and pathology.","date":"2011","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/21248146","citation_count":85,"is_preprint":false},{"pmid":"19956657","id":"PMC_19956657","title":"The specificity of the FOXL2 c.402C>G somatic mutation: a survey of solid tumors.","date":"2009","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/19956657","citation_count":83,"is_preprint":false},{"pmid":"15591279","id":"PMC_15591279","title":"A recurrent polyalanine expansion in the transcription factor FOXL2 induces extensive nuclear and cytoplasmic protein aggregation.","date":"2004","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/15591279","citation_count":82,"is_preprint":false},{"pmid":"28091399","id":"PMC_28091399","title":"Sex determination and maintenance: the role of DMRT1 and FOXL2.","date":"2017","source":"Asian journal of andrology","url":"https://pubmed.ncbi.nlm.nih.gov/28091399","citation_count":75,"is_preprint":false},{"pmid":"21289058","id":"PMC_21289058","title":"Transcription factor FOXL2 protects granulosa cells from stress and delays cell cycle: role of its regulation by the SIRT1 deacetylase.","date":"2011","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21289058","citation_count":74,"is_preprint":false},{"pmid":"31712577","id":"PMC_31712577","title":"RUNX1 maintains the identity of the fetal ovary through an interplay with FOXL2.","date":"2019","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/31712577","citation_count":73,"is_preprint":false},{"pmid":"23516377","id":"PMC_23516377","title":"Microhomology-mediated mechanisms underlie non-recurrent disease-causing microdeletions of the FOXL2 gene or its regulatory domain.","date":"2013","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23516377","citation_count":72,"is_preprint":false},{"pmid":"24739304","id":"PMC_24739304","title":"Follicle-stimulating hormone synthesis and fertility depend on SMAD4 and FOXL2.","date":"2014","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/24739304","citation_count":68,"is_preprint":false},{"pmid":"21763750","id":"PMC_21763750","title":"The transcription factor FOXL2: at the crossroads of ovarian physiology and pathology.","date":"2011","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/21763750","citation_count":67,"is_preprint":false},{"pmid":"20098707","id":"PMC_20098707","title":"Functional exploration of the adult ovarian granulosa cell tumor-associated somatic FOXL2 mutation p.Cys134Trp (c.402C>G).","date":"2010","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/20098707","citation_count":66,"is_preprint":false},{"pmid":"23348906","id":"PMC_23348906","title":"FOXL2 molecular testing in ovarian neoplasms: diagnostic approach and procedural guidelines.","date":"2013","source":"Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc","url":"https://pubmed.ncbi.nlm.nih.gov/23348906","citation_count":65,"is_preprint":false},{"pmid":"23029457","id":"PMC_23029457","title":"The transcriptional targets of mutant FOXL2 in granulosa cell tumours.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23029457","citation_count":64,"is_preprint":false},{"pmid":"23340250","id":"PMC_23340250","title":"Impaired fertility and FSH synthesis in gonadotrope-specific Foxl2 knockout mice.","date":"2013","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/23340250","citation_count":61,"is_preprint":false},{"pmid":"17430735","id":"PMC_17430735","title":"Extinction of FOXL2 expression in aggressive ovarian granulosa cell tumors in children.","date":"2007","source":"Fertility and sterility","url":"https://pubmed.ncbi.nlm.nih.gov/17430735","citation_count":60,"is_preprint":false},{"pmid":"16153597","id":"PMC_16153597","title":"Transcriptional factor FOXL2 interacts with DP103 and induces apoptosis.","date":"2005","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/16153597","citation_count":58,"is_preprint":false},{"pmid":"17089161","id":"PMC_17089161","title":"A novel polyalanine expansion in FOXL2: the first evidence for a recessive form of the blepharophimosis syndrome (BPES) associated with ovarian dysfunction.","date":"2006","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17089161","citation_count":58,"is_preprint":false},{"pmid":"21622537","id":"PMC_21622537","title":"SMADs and FOXL2 synergistically regulate murine FSHbeta transcription via a conserved proximal promoter element.","date":"2011","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/21622537","citation_count":56,"is_preprint":false},{"pmid":"18155828","id":"PMC_18155828","title":"The mutations and potential targets of the forkhead transcription factor FOXL2.","date":"2007","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/18155828","citation_count":55,"is_preprint":false},{"pmid":"18384673","id":"PMC_18384673","title":"R-spondin1 and FOXL2 act into two distinct cellular types during goat ovarian differentiation.","date":"2008","source":"BMC developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/18384673","citation_count":55,"is_preprint":false},{"pmid":"23044875","id":"PMC_23044875","title":"WNT4, RSPO1, and FOXL2 in sex development.","date":"2012","source":"Seminars in reproductive medicine","url":"https://pubmed.ncbi.nlm.nih.gov/23044875","citation_count":54,"is_preprint":false},{"pmid":"33741713","id":"PMC_33741713","title":"Germline sexual fate is determined by the antagonistic action of dmrt1 and foxl3/foxl2 in tilapia.","date":"2021","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/33741713","citation_count":52,"is_preprint":false},{"pmid":"27649556","id":"PMC_27649556","title":"Involvement of FOXL2 and RSPO1 in Ovarian Determination, Development, and Maintenance in Mammals.","date":"2016","source":"Sexual development : genetics, molecular biology, evolution, endocrinology, embryology, and pathology of sex determination and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/27649556","citation_count":51,"is_preprint":false},{"pmid":"26791928","id":"PMC_26791928","title":"Impact of FOXL2 mutations on signaling in ovarian granulosa cell tumors.","date":"2016","source":"The international journal of biochemistry & cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/26791928","citation_count":50,"is_preprint":false},{"pmid":"22116255","id":"PMC_22116255","title":"Loss of R-spondin1 and Foxl2 amplifies female-to-male sex reversal in XX mice.","date":"2011","source":"Sexual development : genetics, molecular biology, evolution, endocrinology, embryology, and pathology of sex determination and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/22116255","citation_count":49,"is_preprint":false},{"pmid":"26939755","id":"PMC_26939755","title":"WNT/β-catenin and p27/FOXL2 differentially regulate supporting cell proliferation in the developing ovary.","date":"2016","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/26939755","citation_count":48,"is_preprint":false},{"pmid":"15300845","id":"PMC_15300845","title":"The human FOXL2 mutation database.","date":"2004","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/15300845","citation_count":47,"is_preprint":false},{"pmid":"30212841","id":"PMC_30212841","title":"Genome-wide identification of FOXL2 binding and characterization of FOXL2 feminizing action in the fetal gonads.","date":"2018","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/30212841","citation_count":47,"is_preprint":false},{"pmid":"32641411","id":"PMC_32641411","title":"Mutant FOXL2C134W Hijacks SMAD4 and SMAD2/3 to Drive Adult Granulosa Cell Tumors.","date":"2020","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/32641411","citation_count":44,"is_preprint":false},{"pmid":"19819892","id":"PMC_19819892","title":"FOXL2 mutations lead to different ovarian phenotypes in BPES patients: Case Report.","date":"2009","source":"Human reproduction (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/19819892","citation_count":44,"is_preprint":false},{"pmid":"22742556","id":"PMC_22742556","title":"FOXL2 mutations in granulosa cell tumors occurring in males.","date":"2012","source":"Archives of pathology & laboratory medicine","url":"https://pubmed.ncbi.nlm.nih.gov/22742556","citation_count":44,"is_preprint":false},{"pmid":"33432361","id":"PMC_33432361","title":"Functional Divergence of Multiple Duplicated Foxl2 Homeologs and Alleles in a Recurrent Polyploid Fish.","date":"2021","source":"Molecular biology and evolution","url":"https://pubmed.ncbi.nlm.nih.gov/33432361","citation_count":43,"is_preprint":false},{"pmid":"27604691","id":"PMC_27604691","title":"The genetic make-up of ovarian development and function: the focus on the transcription factor FOXL2.","date":"2016","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/27604691","citation_count":42,"is_preprint":false},{"pmid":"30246781","id":"PMC_30246781","title":"FOXL2 and DMRT1L Are Yin and Yang Genes for Determining Timing of Sex Differentiation in the Bivalve Mollusk Patinopecten yessoensis.","date":"2018","source":"Frontiers in physiology","url":"https://pubmed.ncbi.nlm.nih.gov/30246781","citation_count":42,"is_preprint":false},{"pmid":"24451388","id":"PMC_24451388","title":"FOXL2 transcriptionally represses Sf1 expression by antagonizing WT1 during ovarian development in mice.","date":"2014","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/24451388","citation_count":41,"is_preprint":false},{"pmid":"31162286","id":"PMC_31162286","title":"Adult Granulosa Cell Tumor With High-grade Transformation: Report of a Series With FOXL2 Mutation Analysis.","date":"2019","source":"The American journal of surgical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/31162286","citation_count":38,"is_preprint":false},{"pmid":"32782329","id":"PMC_32782329","title":"Phytoestrogen genistein hinders ovarian oxidative damage and apoptotic cell death-induced by ionizing radiation: co-operative role of ER-β, TGF-β, and FOXL-2.","date":"2020","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/32782329","citation_count":38,"is_preprint":false},{"pmid":"24390485","id":"PMC_24390485","title":"FOXL2 posttranslational modifications mediated by GSK3β determine the growth of granulosa cell tumours.","date":"2014","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/24390485","citation_count":37,"is_preprint":false},{"pmid":"22019437","id":"PMC_22019437","title":"FTZ-F1 and FOXL2 up-regulate catfish brain aromatase gene transcription by specific binding to the promoter motifs.","date":"2011","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/22019437","citation_count":37,"is_preprint":false},{"pmid":"28938467","id":"PMC_28938467","title":"Testis Determination Requires a Specific FGFR2 Isoform to Repress FOXL2.","date":"2017","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/28938467","citation_count":36,"is_preprint":false},{"pmid":"25363394","id":"PMC_25363394","title":"Molecular cloning and analysis of gonadal expression of Foxl2 in the rice-field eel Monopterus albus.","date":"2014","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/25363394","citation_count":36,"is_preprint":false},{"pmid":"33428330","id":"PMC_33428330","title":"Adult-type granulosa cell tumor of the ovary: a FOXL2-centric disease.","date":"2021","source":"The journal of pathology. Clinical research","url":"https://pubmed.ncbi.nlm.nih.gov/33428330","citation_count":35,"is_preprint":false},{"pmid":"24973035","id":"PMC_24973035","title":"Positive cross talk between FOXL2 and antimüllerian hormone regulates ovarian reserve.","date":"2014","source":"Fertility and sterility","url":"https://pubmed.ncbi.nlm.nih.gov/24973035","citation_count":34,"is_preprint":false},{"pmid":"31505465","id":"PMC_31505465","title":"FOXL2 antagonises the male developmental pathway in embryonic chicken gonads.","date":"2019","source":"The Journal of endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/31505465","citation_count":33,"is_preprint":false},{"pmid":"21700720","id":"PMC_21700720","title":"Impaired FSHbeta expression in the pituitaries of Foxl2 mutant animals.","date":"2011","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/21700720","citation_count":33,"is_preprint":false},{"pmid":"19339816","id":"PMC_19339816","title":"Xenopus W-linked DM-W induces Foxl2 and Cyp19 expression during ovary formation.","date":"2009","source":"Sexual development : genetics, molecular biology, evolution, endocrinology, embryology, and pathology of sex determination and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/19339816","citation_count":33,"is_preprint":false},{"pmid":"25687138","id":"PMC_25687138","title":"Role of Foxl2 in uterine maturation and function.","date":"2015","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/25687138","citation_count":32,"is_preprint":false},{"pmid":"25621074","id":"PMC_25621074","title":"MiR-30a upregulates BCL2A1, IER3 and cyclin D2 expression by targeting FOXL2.","date":"2014","source":"Oncology letters","url":"https://pubmed.ncbi.nlm.nih.gov/25621074","citation_count":32,"is_preprint":false},{"pmid":"15820304","id":"PMC_15820304","title":"Sense and antisense Foxl2 transcripts in mouse.","date":"2005","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/15820304","citation_count":30,"is_preprint":false},{"pmid":"34727551","id":"PMC_34727551","title":"The Genetics and Biology of FOXL2.","date":"2021","source":"Sexual development : genetics, molecular biology, evolution, endocrinology, embryology, and pathology of sex determination and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/34727551","citation_count":29,"is_preprint":false},{"pmid":"24342437","id":"PMC_24342437","title":"The role of FOXL2 in the pathogenesis of adult ovarian granulosa cell tumours.","date":"2013","source":"Gynecologic oncology","url":"https://pubmed.ncbi.nlm.nih.gov/24342437","citation_count":29,"is_preprint":false},{"pmid":"21208465","id":"PMC_21208465","title":"Expression and localization of forkhead transcriptional factor 2 (Foxl2) in the gonads of protogynous wrasse, Halichoeres trimaculatus.","date":"2010","source":"Biology of sex differences","url":"https://pubmed.ncbi.nlm.nih.gov/21208465","citation_count":29,"is_preprint":false},{"pmid":"8689480","id":"PMC_8689480","title":"Blepharophimosis-ptosis-epicanthus inversus syndrome (BPES).","date":"1996","source":"Acta ophthalmologica Scandinavica","url":"https://pubmed.ncbi.nlm.nih.gov/8689480","citation_count":28,"is_preprint":false},{"pmid":"31537253","id":"PMC_31537253","title":"Roles of forkhead box protein L2 (foxl2) during gonad differentiation and maintenance in a fish, the olive flounder (Paralichthys olivaceus).","date":"2019","source":"Reproduction, fertility, and development","url":"https://pubmed.ncbi.nlm.nih.gov/31537253","citation_count":28,"is_preprint":false},{"pmid":"12567411","id":"PMC_12567411","title":"FOXL2-mutations in blepharophimosis-ptosis-epicanthus inversus syndrome (BPES); challenges for genetic counseling in female patients.","date":"2003","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/12567411","citation_count":28,"is_preprint":false},{"pmid":"19797124","id":"PMC_19797124","title":"Foxl2, a forkhead transcription factor, modulates nonclassical activity of the estrogen receptor-alpha.","date":"2009","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/19797124","citation_count":28,"is_preprint":false},{"pmid":"12400065","id":"PMC_12400065","title":"Mutations in FOXL2 underlying BPES (types 1 and 2) in Colombian families.","date":"2002","source":"American journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/12400065","citation_count":27,"is_preprint":false},{"pmid":"23051594","id":"PMC_23051594","title":"Clusterin and FOXL2 act concordantly to regulate pituitary gonadotroph adenoma growth.","date":"2012","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/23051594","citation_count":26,"is_preprint":false},{"pmid":"25317675","id":"PMC_25317675","title":"microRNA133a targets Foxl2 and promotes differentiation of C2C12 into myogenic progenitor cells.","date":"2015","source":"DNA and cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/25317675","citation_count":26,"is_preprint":false},{"pmid":"26430246","id":"PMC_26430246","title":"FOXL2 down-regulates vitellogenin expression at mature stage in Eriocheir sinensis.","date":"2015","source":"Bioscience reports","url":"https://pubmed.ncbi.nlm.nih.gov/26430246","citation_count":25,"is_preprint":false},{"pmid":"29800110","id":"PMC_29800110","title":"Conditional Deletion of FOXL2 and SMAD4 in Gonadotropes of Adult Mice Causes Isolated FSH Deficiency.","date":"2018","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/29800110","citation_count":25,"is_preprint":false},{"pmid":"28319575","id":"PMC_28319575","title":"FOXL2 Mutation Status in Granulosa Theca Cell Tumors of the Ovary.","date":"2017","source":"International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists","url":"https://pubmed.ncbi.nlm.nih.gov/28319575","citation_count":24,"is_preprint":false},{"pmid":"36575161","id":"PMC_36575161","title":"Dissecting the fate of Foxl2-expressing cells in fetal ovary using lineage tracing and single-cell transcriptomics.","date":"2022","source":"Cell discovery","url":"https://pubmed.ncbi.nlm.nih.gov/36575161","citation_count":24,"is_preprint":false},{"pmid":"32641414","id":"PMC_32641414","title":"The Pathognomonic FOXL2 C134W Mutation Alters DNA-Binding Specificity.","date":"2020","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/32641414","citation_count":23,"is_preprint":false},{"pmid":"32814714","id":"PMC_32814714","title":"Ovarian granulosa cell tumor characterization identifies FOXL2 as an immunotherapeutic target.","date":"2020","source":"JCI insight","url":"https://pubmed.ncbi.nlm.nih.gov/32814714","citation_count":23,"is_preprint":false},{"pmid":"33215742","id":"PMC_33215742","title":"An alternative miRISC targets a cancer-associated coding sequence mutation in FOXL2.","date":"2020","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/33215742","citation_count":23,"is_preprint":false},{"pmid":"22294749","id":"PMC_22294749","title":"FOXL2 is involved in the synergy between activin and progestins on the follicle-stimulating hormone β-subunit promoter.","date":"2012","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/22294749","citation_count":23,"is_preprint":false},{"pmid":"32910017","id":"PMC_32910017","title":"Rare DICER1 and Absent FOXL2 Mutations Characterize Ovarian Juvenile Granulosa Cell Tumors.","date":"2021","source":"The American journal of surgical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/32910017","citation_count":22,"is_preprint":false},{"pmid":"20429427","id":"PMC_20429427","title":"FOXL2: at the crossroads of female sex determination and ovarian function.","date":"2009","source":"Advances in experimental medicine and biology","url":"https://pubmed.ncbi.nlm.nih.gov/20429427","citation_count":22,"is_preprint":false},{"pmid":"26134413","id":"PMC_26134413","title":"FOXL2 modulates cartilage, skeletal development and IGF1-dependent growth in mice.","date":"2015","source":"BMC developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/26134413","citation_count":22,"is_preprint":false},{"pmid":"24332943","id":"PMC_24332943","title":"FOXL2-induced follistatin attenuates activin A-stimulated cell proliferation in human granulosa cell tumors.","date":"2013","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/24332943","citation_count":22,"is_preprint":false},{"pmid":"18484667","id":"PMC_18484667","title":"Differential functional effects of novel mutations of the transcription factor FOXL2 in BPES patients.","date":"2008","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/18484667","citation_count":22,"is_preprint":false},{"pmid":"19747961","id":"PMC_19747961","title":"The forkhead factor FOXL2: a novel tumor suppressor?","date":"2009","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/19747961","citation_count":22,"is_preprint":false},{"pmid":"22623620","id":"PMC_22623620","title":"FOXL2 is regulated during the bovine estrous cycle and its expression in the endometrium is independent of conceptus-derived interferon tau.","date":"2012","source":"Biology of reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/22623620","citation_count":22,"is_preprint":false},{"pmid":"21478824","id":"PMC_21478824","title":"Expression of FOXL2 in human normal pituitaries and pituitary adenomas.","date":"2011","source":"Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc","url":"https://pubmed.ncbi.nlm.nih.gov/21478824","citation_count":21,"is_preprint":false},{"pmid":"34224832","id":"PMC_34224832","title":"Characterization of the foxl2 gene involved in the vtg expression in mud crab (Scylla paramamosain).","date":"2021","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/34224832","citation_count":21,"is_preprint":false},{"pmid":"24817949","id":"PMC_24817949","title":"FOXL2 suppresses proliferation, invasion and promotes apoptosis of cervical cancer cells.","date":"2014","source":"International journal of clinical and experimental pathology","url":"https://pubmed.ncbi.nlm.nih.gov/24817949","citation_count":21,"is_preprint":false},{"pmid":"8800926","id":"PMC_8800926","title":"Refined genetic and physical mapping of BPES type II.","date":"1996","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/8800926","citation_count":21,"is_preprint":false},{"pmid":"25550048","id":"PMC_25550048","title":"Characterization and gonadal expression of FOXL2 relative to Cyp19a genes in spotted scat Scatophagus argus.","date":"2014","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/25550048","citation_count":20,"is_preprint":false},{"pmid":"15257268","id":"PMC_15257268","title":"Genetic analysis of a five generation Indian family with BPES: a novel missense mutation (p.Y215C).","date":"2004","source":"Molecular vision","url":"https://pubmed.ncbi.nlm.nih.gov/15257268","citation_count":20,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":49191,"output_tokens":7123,"usd":0.127209},"stage2":{"model":"claude-opus-4-6","input_tokens":10885,"output_tokens":3994,"usd":0.231412},"total_usd":0.358621,"stage1_batch_id":"msgbatch_0118RScg3WGaGkaZRtWZbtce","stage2_batch_id":"msgbatch_01Cpfzvtbj42aqp5oYZ5Te2s","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2004,\n      \"finding\": \"Murine Foxl2 is required for granulosa cell differentiation (squamous-to-cuboidal transition) and ovary maintenance; loss of Foxl2 leads to absence of secondary follicles, oocyte atresia, and loss of activin-betaA and AMH expression, while causing premature activation of primordial follicles\",\n      \"method\": \"Foxl2(lacZ) homozygous knockout mouse model with histological analysis, gene expression studies\",\n      \"journal\": \"Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with defined cellular and molecular phenotypes, replicated across labs\",\n      \"pmids\": [\"14736745\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Combined inactivation of Wnt4 and Foxl2 in XX mice produces full female-to-male sex reversal including testis tubule formation and spermatogonia; forced expression of Foxl2 impairs testis tubule differentiation in XY transgenic mice, demonstrating an anti-testis role for Foxl2\",\n      \"method\": \"Double knockout mouse genetics, transgenic overexpression, histological analysis\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis with orthogonal gain- and loss-of-function experiments\",\n      \"pmids\": [\"17728319\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Polyalanine expansion mutations in FOXL2 (14 to 24 alanines) cause extensive intranuclear aggregation and cytoplasmic mislocalisation of the protein; wild-type and mutant proteins can co-aggregate, suggesting a dominant-negative mechanism via sequestration\",\n      \"method\": \"Transfection of GFP-fusion constructs in COS-7 cells, immunofluorescence\",\n      \"journal\": \"Journal of medical genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — single lab, transfection with fluorescence imaging, moderate follow-up\",\n      \"pmids\": [\"15591279\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"FOXL2 is expressed in pituitary gonadotropes and thyrotropes co-localizing with the glycoprotein hormone alpha-subunit (αGSU/Cga); FOXL2 regulates Cga transcription in gonadotrope-derived cells in a context-dependent manner, and a FOXL2-VP16 fusion drives ectopic Cga expression in transgenic animals; FOXL2 expression requires Lhx3 and Lhx4\",\n      \"method\": \"Immunofluorescence co-localization, reporter assays in multiple cell lines, transgenic mice, epistasis analysis\",\n      \"journal\": \"Molecular endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (reporter assay, transgenic rescue, co-localization, genetic epistasis)\",\n      \"pmids\": [\"16840539\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"FoxL2 binds a forkhead-binding element (FKHB) adjacent to a Smad-binding element (SBE1) in the follistatin gene intron, directly associates with Smad3 (but not Smad2 or Smad4) via Smad3's MH2 domain in an interaction requiring an intact FoxL2 forkhead domain, and functions as a Smad3 partner to drive SBE1-mediated follistatin transcription in activin-treated gonadotrope cells\",\n      \"method\": \"Proteomics/co-IP identification, reporter assays, ChIP, shRNA knockdown, domain-mapping co-IP\",\n      \"journal\": \"Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal methods: ChIP, reciprocal co-IP, domain mutagenesis, reporter assays, knockdown\",\n      \"pmids\": [\"19106105\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"FOXL2 physically interacts with steroidogenic factor-1 (SF-1) in granulosa cells (identified by yeast two-hybrid and confirmed by co-IP), and represses SF-1-induced CYP17 transcription by inhibiting SF-1 binding to the CYP17 promoter; BPES-associated FOXL2 mutants lose this repressive activity\",\n      \"method\": \"Yeast two-hybrid screen, co-IP in human granulosa cells, ChIP, EMSA, reporter assays, BPES mutant analysis\",\n      \"journal\": \"Molecular endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal methods confirming physical interaction and functional consequence\",\n      \"pmids\": [\"20207836\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"The FOXL2 p.C134W (c.402C>G) tumor-associated mutation does not strongly alter subcellular localization, solubility, or transactivation on most target promoters compared to wild-type, but does exhibit altered activity on an artificial promoter co-regulated by FOXL2 and Smad3, suggesting a subtle modification of FOXL2–Smad3 interaction; 3D structural modeling indicates homodimer formation may be disturbed\",\n      \"method\": \"Subcellular localization studies, transactivation assays on multiple promoters, FRAP, 3D structural modeling\",\n      \"journal\": \"PLoS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — multiple functional assays but mainly rules out strong effects; structural model is computational\",\n      \"pmids\": [\"20098707\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"FOXL2 upregulation promotes G1 cell-cycle arrest, protects granulosa cells from oxidative damage by promoting oxidized DNA repair and increasing glutathione, and modulates cell-cycle regulator expression; the SIRT1 deacetylase suppresses FOXL2 activity on cell-cycle and DNA repair targets in a dose-dependent manner\",\n      \"method\": \"Functional genomics, cell-cycle analysis (FACS), oxidative stress assays, deacetylase inhibitor experiments, comparison of BPES mutation classes\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal assays including cell biology, pharmacological intervention, and mutation-class comparison\",\n      \"pmids\": [\"21289058\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"In Foxl2 mutant mouse pituitaries, gonadotrope specification is normal but FSHβ expression is severely impaired; activin-induced FSHβ expression and FSH secretion are abolished in primary pituitary cultures from Foxl2 mutant mice, demonstrating that FoxL2 is required for the activin-dependent activation of Fshb transcription\",\n      \"method\": \"Foxl2 mutant mouse analysis, primary pituitary cell cultures, hormone measurement, RT-PCR\",\n      \"journal\": \"Molecular endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo KO combined with primary culture mechanistic validation\",\n      \"pmids\": [\"21700720\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"FOXL2 synergizes with SMAD2, SMAD3, and SMAD4 to stimulate murine Fshb promoter activity; SMAD3-induced Fshb expression depends on endogenous FOXL2; both FOXL2 and SMAD3/4 must bind DNA at adjacent cis-elements (proximal FKH element and SMAD-binding element) for full activin induction of Fshb transcription\",\n      \"method\": \"Reporter assays in heterologous and homologous cells, site-directed mutagenesis of promoter elements, FOXL2-SMAD interaction studies\",\n      \"journal\": \"Molecular endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — epistasis by promoter mutagenesis combined with co-transfection and endogenous knockdown\",\n      \"pmids\": [\"21622537\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"In Foxl2-null mice, early testis genes (Inhbb, Dhh, Sox9) are upregulated and several novel ovarian genes are dysregulated during embryonic development; gene-dosage sensitivity is demonstrated by heterozygous Foxl2 loss; a Foxl2 transgene disrupts embryonic testis differentiation and upregulates female markers, supporting dose-dependent anti-testis action throughout ovary differentiation\",\n      \"method\": \"Transcriptome profiling of Foxl2 knockout and double-mutant ovaries, transgenic rescue, principal component analysis\",\n      \"journal\": \"BMC developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genome-wide expression profiling combined with genetic epistasis and transgenic gain-of-function\",\n      \"pmids\": [\"19538736\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Conditional knockout of Foxl2 in gonadotrope cells causes FSH deficiency, subfertility, and impaired activin-stimulated Fshb expression in primary cultures, establishing FOXL2 as the first gonadotrope-restricted transcription factor required for selective FSH synthesis in vivo\",\n      \"method\": \"Cre/lox conditional knockout, hormone assays, reproductive phenotyping, primary pituitary cultures\",\n      \"journal\": \"Molecular endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean conditional KO with defined endocrine and fertility phenotypes\",\n      \"pmids\": [\"23340250\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Combined conditional deletion of Foxl2 and Smad4 in gonadotropes essentially abolishes FSH synthesis and causes female sterility phenotype comparable to Fshb-knockout mice, establishing SMAD4 and FOXL2 as essential master regulators of Fshb transcription in vivo\",\n      \"method\": \"Double conditional knockout mouse (Cre/lox), FSH measurement, fertility phenotyping\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — double conditional KO with strong phenotypic evidence\",\n      \"pmids\": [\"24739304\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"FOXL2 is required for normal gene regulation by steroid receptors in murine primary follicular cells; FOXL2 directly modulates Esr2 (estrogen receptor beta) expression through a newly identified intronic element; FOXL2 represses Sox9 both independently and through activation of ESR2, establishing a coherent feed-forward loop for ovarian maintenance\",\n      \"method\": \"Primary follicular cell isolation, ChIP-seq, reporter assays, loss-of-function analysis\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — ChIP with functional validation in primary cells and KO model\",\n      \"pmids\": [\"25369636\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"FOXL2 directly transactivates AMH transcription (confirmed by luciferase assay, EMSA, and ChIP); BPES-associated FOXL2 mutants fail to activate AMH; in vivo, ectopic FOXL2 prevents AMH-knockdown-accelerated follicle growth, demonstrating positive cross-regulation between FOXL2 and AMH in ovarian follicle reserve maintenance\",\n      \"method\": \"Luciferase reporter assay, EMSA, ChIP, in vivo mouse gene delivery\",\n      \"journal\": \"Fertility and sterility\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal in vitro and in vivo methods\",\n      \"pmids\": [\"24973035\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"FOXL2 transcriptionally represses Sf1 by antagonizing WT1-KTS activation of the Sf1 proximal promoter; a conserved FOXL2 binding site was identified by ChIP; mutations abolishing this site eliminate FOXL2-mediated repression; in Foxl2-null mice, Sf1 expression is increased 2-fold in XX fetal gonads\",\n      \"method\": \"Reporter assays, ChIP, site-directed mutagenesis, Foxl2-null mouse analysis\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vitro mechanistic assays confirmed in vivo by KO mouse\",\n      \"pmids\": [\"24451388\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"The C134W FOXL2 mutation undergoes differential post-translational modifications compared to wild-type: GSK3β hyperphosphorylates C134W at serine 33, inducing MDM2-mediated ubiquitination and proteasomal degradation; wild-type FOXL2 is underphosphorylated at S33, leading to SUMOylation and stabilization; S33 phosphorylation status correlates with GCT oncogenicity in xenograft mice, and GSK3β inhibition represses GCT growth\",\n      \"method\": \"In vitro kinase assays, mutagenesis, ubiquitination and SUMOylation assays, xenograft mouse model, patient tissue analysis\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — reconstituted PTM cascade with in vivo validation in xenograft and patient tissue\",\n      \"pmids\": [\"24390485\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"FOXL2 interacts with DP103 (a DEAD-box RNA helicase) and induces apoptosis in CHO cells and rat granulosa cells; DP103 co-expression potentiates FOXL2-induced cell death\",\n      \"method\": \"Co-immunoprecipitation, overexpression in CHO and granulosa cells, cell viability assays\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — single lab, co-IP plus functional assay\",\n      \"pmids\": [\"16153597\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Foxl2 suppresses ERα-mediated transcription through nonclassical (AP1-tethered) pathways but has no effect on classical ERE-dependent ERα transcription; Foxl2 physically interacts with ERα (co-IP); Foxl2 represses COX2 expression induced by ERα/tamoxifen signaling\",\n      \"method\": \"Reporter assays (AP1 and ERE), co-IP, expression profiling, western blotting\",\n      \"journal\": \"Endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — co-IP plus functional reporters and expression data, single lab\",\n      \"pmids\": [\"19797124\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"FOXL2 directly stimulates the clusterin (Clu) gene promoter in pituitary gonadotroph cells; FOXL2 also binds and suppresses the PTTG promoter; together, FOXL2 and Clu restrain pituitary gonadotroph tumor cell proliferation by inducing CDK inhibitors p16 and p27; in vivo, gonadotroph xenografts overexpressing Clu and FOXL2 grow slower\",\n      \"method\": \"Reporter assays, ChIP (implied by direct stimulation claim), xenograft mouse model, cell proliferation assays\",\n      \"journal\": \"Molecular endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — reporter assays with in vivo xenograft validation; mechanistic detail moderate\",\n      \"pmids\": [\"23051594\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Wild-type FOXL2 (but not C134W mutant) induces follistatin production in KGN cells, and exogenous follistatin blocks activin A-stimulated cell proliferation; thus wild-type FOXL2 acts as a tumor suppressor by inducing follistatin that antagonizes activin-stimulated granulosa cell proliferation\",\n      \"method\": \"FOXL2 overexpression, follistatin ELISA/western blotting, exogenous follistatin rescue, KGN cell proliferation assays\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — single lab, overexpression with rescue experiment\",\n      \"pmids\": [\"24332943\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"FOXL2 is involved in activin/progestin synergy on the Fshb promoter; FOXL2 physically interacts with progesterone receptor (PR) and SMAD3; multiple Fshb promoter elements binding FOXL2, SMADs, and PR are required for full synergistic response\",\n      \"method\": \"Reporter assays, co-IP, promoter mutagenesis\",\n      \"journal\": \"Endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — co-IP and promoter mutagenesis, single lab\",\n      \"pmids\": [\"22294749\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Genome-wide ChIP-seq of FOXL2 in fetal mouse ovaries shows extensive overlap with SOX9 occupancy in the fetal testis; ectopic FOXL2 expression in fetal testis somatic precursors represses Sertoli cell differentiation and causes partial testis-to-ovary sex reversal, demonstrating FOXL2 is sufficient to feminize the gonad\",\n      \"method\": \"ChIP-seq, gain-of-function transgenic mouse model, transcriptomic analysis\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — ChIP-seq combined with gain-of-function mouse genetics\",\n      \"pmids\": [\"30212841\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"RUNX1 plays complementary/redundant roles with FOXL2 in maintaining fetal granulosa cell identity; combined loss of RUNX1 and FOXL2 results in masculinization of fetal ovaries; ChIP-seq shows RUNX1 occupancy partially overlaps with FOXL2 occupancy in fetal ovary, suggesting co-regulation of common gene targets\",\n      \"method\": \"Double conditional knockout mouse, ChIP-seq, single-cell transcriptomics\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — double KO epistasis combined with ChIP-seq chromatin-level evidence\",\n      \"pmids\": [\"31712577\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"The FOXL2 C134W mutant acquires the ability to bind SMAD4, forming a novel FOXL2C134W/SMAD4/SMAD2/3 complex that binds a hybrid DNA motif (AGHCAHAA) unique to the mutant; this binding induces an enhancer-like chromatin state activating nearby genes associated with EMT; ablation of SMAD4 or SMAD2/3 strongly reduces FOXL2C134W binding at hybrid sites\",\n      \"method\": \"ChIP-seq, co-IP, CRISPR ablation of SMAD4/SMAD2/3, chromatin state analysis, transcriptomics in primary AGCT\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal genome-wide and biochemical methods, replicated in primary tumors\",\n      \"pmids\": [\"32641411\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"The FOXL2 C134W mutation alters DNA-binding specificity genome-wide; FOXL2C134W associates with the majority of wild-type FOXL2 binding sites as well as a large set of unique sites; altered binding drives an oncogenic transcriptional program including SLC35F2 upregulation, which increases sensitivity to YM155\",\n      \"method\": \"ChIP-seq and transcriptome profiling in V5-FOXL2WT vs. V5-FOXL2C134W isogenic inducible cell lines\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — isogenic cell lines with genome-wide ChIP-seq and transcriptomics; functional drug sensitivity validation\",\n      \"pmids\": [\"32641414\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"The FOXL2 C134W somatic mutation introduces a target site for miR-1236 in the coding sequence; miR-1236 selectively degrades variant FOXL2 mRNA via a non-canonical miRISC directed by AGO3 and DHX9, causing haploinsufficiency of tumor-suppressor FOXL2 in AGCTs\",\n      \"method\": \"miRNA target site mutagenesis, AGO3/DHX9 co-IP, miR-1236 gain/loss-of-function, patient sample correlation, mouse AGCT model\",\n      \"journal\": \"EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods including biochemistry, genetics and in vivo validation\",\n      \"pmids\": [\"33215742\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Conditional deletion of Foxl2 in the postnatal uterus using Pgr-cre results in infertility, reduced stromal thickness, hypertrophic/disorganized inner myometrial layer, failure of vascular smooth muscle organization, and deregulation of Wnt signaling genes, demonstrating a role for FOXL2 in uterine maturation\",\n      \"method\": \"Conditional knockout mouse (Pgr-cre; Foxl2flox/flox), histological analysis, gene expression profiling\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean conditional KO with defined structural and molecular phenotypes\",\n      \"pmids\": [\"25687138\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Conditional deletion of both Foxl2 and Smad4 in gonadotrope cells of adult mice (using tamoxifen-inducible Cre) causes profound FSH reduction, arrested ovarian follicle development, and sterility, demonstrating that FOXL2 and SMAD4 are continuously required for FSH synthesis in adult gonadotropes\",\n      \"method\": \"Tamoxifen-inducible conditional double KO, FSH ELISA, histological analysis of ovaries\",\n      \"journal\": \"Endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — inducible adult-specific KO distinguishing developmental from maintenance roles\",\n      \"pmids\": [\"29800110\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Foxl2-null mice show defects in postnatal growth, embryonic bone and cartilage formation, and down-regulation of the GH/IGF1 axis; FOXL2 is expressed in neural tube epithelium, head mesenchyme, cartilaginous tissue, and hypothalamus during development; FOXL2 and SOX9 act jointly in cartilage development despite being antagonistic in gonadal sex determination\",\n      \"method\": \"Foxl2 knockout mouse, skeletal staining, immunofluorescence, microarray, RT-qPCR for GH/IGF1 pathway\",\n      \"journal\": \"BMC developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — KO with skeletal phenotype and expression data, single lab\",\n      \"pmids\": [\"26134413\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Lineage tracing of Foxl2-expressing cells in fetal mouse ovaries reveals that they are multipotent, giving rise not only to granulosa cells but also to theca-interstitial cells (Theca-G) and stromal cells; single-cell RNA-seq shows two FOXL2-positive clusters at P0, one differentiating into granulosa/Theca-G and another into stromal/Theca-S lineages\",\n      \"method\": \"Genetic lineage tracing (Cre/Rosa reporter), single-cell RNA-seq across developmental time points\",\n      \"journal\": \"Cell discovery\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — lineage tracing with scRNA-seq provides direct cellular fate mapping\",\n      \"pmids\": [\"36575161\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"FOXL2 is a forkhead transcription factor that acts as a master regulator of ovarian granulosa cell identity: it drives granulosa cell differentiation, represses testis-determining genes (Sox9, Sf1) by binding their promoters and antagonizing WT1/RUNX1, activates ovarian targets (AMH, follistatin, ESR2/estrogen receptor beta, aromatase) via direct DNA binding and cooperative interactions with SMAD2/3/4, PR, and SF-1, and is required in pituitary gonadotropes—together with SMAD4—for activin-stimulated Fshb transcription; post-translational regulation of FOXL2 by GSK3β-mediated phosphorylation, MDM2-mediated ubiquitination, and SIRT1-mediated deacetylation modulates its stability and activity, while the pathognomonic C134W somatic mutation found in virtually all adult-type granulosa cell tumors alters DNA-binding specificity and hijacks SMAD4/SMAD2/3 to engage an oncogenic transcriptional program, and is also selectively degraded by a non-canonical AGO3/DHX9–miR-1236 miRISC complex that causes tumor-suppressor haploinsufficiency.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"FOXL2 is a forkhead-domain transcription factor that serves as a master regulator of female gonadal identity, granulosa cell differentiation, and pituitary FSH synthesis. In the ovary, FOXL2 maintains female fate by directly repressing testis-determining genes (Sox9, Sf1) and activating ovarian targets (AMH, follistatin, ESR2, aromatase) through cooperative DNA binding with SMAD2/3, SMAD4, SF-1, progesterone receptor, and RUNX1 at adjacent forkhead and SMAD binding elements; loss of FOXL2 causes granulosa cell differentiation failure and, together with loss of Wnt4 or RUNX1, leads to female-to-male sex reversal [PMID:14736745, PMID:17728319, PMID:31712577, PMID:25369636, PMID:24451388]. In pituitary gonadotropes, FOXL2 and SMAD4 are jointly essential for activin-stimulated Fshb transcription and FSH secretion, as conditional deletion of either or both abolishes FSH synthesis and causes infertility [PMID:23340250, PMID:24739304, PMID:29800110]. The somatic C134W mutation, which is pathognomonic of adult-type granulosa cell tumors, alters FOXL2 DNA-binding specificity genome-wide and enables formation of a neomorphic FOXL2-SMAD4-SMAD2/3 complex that activates an oncogenic transcriptional program, while also creating a coding-sequence target for miR-1236-mediated selective degradation of the mutant allele via AGO3/DHX9, producing tumor-suppressor haploinsufficiency [PMID:32641411, PMID:32641414, PMID:33215742].\",\n  \"teleology\": [\n    {\n      \"year\": 2004,\n      \"claim\": \"Establishing FOXL2 as essential for granulosa cell differentiation answered whether this transcription factor was required for ovary formation and folliculogenesis.\",\n      \"evidence\": \"Foxl2-lacZ homozygous knockout mice showing absence of secondary follicles, loss of squamous-to-cuboidal transition, and loss of AMH/activin-βA expression\",\n      \"pmids\": [\"14736745\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Downstream direct transcriptional targets not yet mapped genome-wide\", \"Whether FOXL2 functions cell-autonomously in granulosa cells vs. through paracrine effects not resolved\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Identification of DP103 as a FOXL2 interactor and demonstration of FOXL2-induced apoptosis suggested a pro-apoptotic function beyond transcriptional regulation of differentiation.\",\n      \"evidence\": \"Co-IP of FOXL2-DP103 and cell viability assays in CHO and rat granulosa cells\",\n      \"pmids\": [\"16153597\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Not independently replicated\", \"Physiological relevance of DP103 interaction in vivo unknown\", \"Mechanism of FOXL2-induced apoptosis not delineated\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Demonstrating FOXL2 expression and function in pituitary gonadotropes expanded its role beyond the ovary to neuroendocrine regulation of reproduction.\",\n      \"evidence\": \"Immunofluorescence co-localization with αGSU, reporter assays in gonadotrope cell lines, transgenic FOXL2-VP16 driving ectopic Cga expression\",\n      \"pmids\": [\"16840539\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct DNA-binding sites on Cga not mapped\", \"Relationship to FSH regulation not yet established\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Genetic epistasis showing that combined Wnt4/Foxl2 loss causes complete female-to-male sex reversal, and that forced FOXL2 impairs testis formation, established FOXL2 as a bona fide anti-testis factor.\",\n      \"evidence\": \"Double knockout and transgenic overexpression mouse genetics with histological analysis\",\n      \"pmids\": [\"17728319\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular targets through which FOXL2 antagonizes testis fate not yet identified at chromatin level\", \"Whether FOXL2 and Wnt4 converge on common downstream effectors unknown\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Identifying FOXL2 as a SMAD3 partner on the follistatin gene intron revealed the mechanistic basis for FOXL2's integration into TGF-β/activin signaling.\",\n      \"evidence\": \"Reciprocal co-IP, domain mapping, ChIP, and shRNA knockdown in gonadotrope cells\",\n      \"pmids\": [\"19106105\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether FOXL2-SMAD3 interaction extends genome-wide to other activin targets not determined\", \"SMAD4 role in this specific complex unclear\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Discovery that FOXL2 physically interacts with SF-1 to repress CYP17 transcription established a mechanism for maintaining granulosa (vs. theca/Leydig) steroidogenic identity.\",\n      \"evidence\": \"Yeast two-hybrid, co-IP in human granulosa cells, ChIP, EMSA, and BPES mutant loss-of-function\",\n      \"pmids\": [\"20207836\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Other SF-1 target genes co-regulated by FOXL2 not systematically identified\", \"In vivo validation by conditional KO of FOXL2-SF1 interaction not performed\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Demonstrating that FOXL2 promotes G1 arrest, oxidative stress protection, and DNA repair — modulated by SIRT1 deacetylation — revealed cell-protective functions beyond transcriptional sex determination.\",\n      \"evidence\": \"FACS cell-cycle analysis, oxidative stress assays, deacetylase inhibitor treatment, BPES mutation-class comparison\",\n      \"pmids\": [\"21289058\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific acetylation sites on FOXL2 targeted by SIRT1 not mapped\", \"In vivo relevance of SIRT1-FOXL2 axis in ovary not tested\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Showing that Foxl2-mutant pituitaries fail to produce FSH upon activin stimulation, and that FOXL2 cooperates with SMADs at adjacent Fshb promoter elements, established FOXL2 as the first gonadotrope-specific transcription factor required for FSH synthesis.\",\n      \"evidence\": \"Foxl2 mutant mouse pituitaries, primary pituitary cultures, reporter assays with promoter mutagenesis\",\n      \"pmids\": [\"21700720\", \"21622537\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether FOXL2 is sufficient to confer Fshb expression on non-gonadotrope cells unknown\", \"Chromatin-level occupancy at endogenous Fshb locus not shown\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"A series of conditional knockout and target-gene studies collectively defined FOXL2's direct transcriptional targets (AMH, ESR2, Sf1, Sox9) and the feed-forward logic by which it maintains ovarian identity: FOXL2 activates ESR2, which cooperatively represses Sox9, while FOXL2 directly represses Sf1 by antagonizing WT1.\",\n      \"evidence\": \"ChIP-seq in primary follicular cells, conditional gonadotrope KOs, reporter assays, EMSA, in vivo gene delivery, double conditional KOs with SMAD4\",\n      \"pmids\": [\"25369636\", \"24451388\", \"24973035\", \"23340250\", \"24739304\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full enhancer-level regulatory network connecting FOXL2 to all ovarian identity genes not mapped\", \"How FOXL2 target selection differs between fetal and adult ovary not resolved\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Elucidation of the GSK3β → S33 phosphorylation → MDM2 ubiquitination cascade for C134W FOXL2 degradation vs. SUMOylation-mediated stabilization of wild-type FOXL2 provided a post-translational mechanism for how the oncogenic mutant is differentially regulated.\",\n      \"evidence\": \"In vitro kinase assays, ubiquitination/SUMOylation assays, mutagenesis, xenograft model, patient tissue analysis\",\n      \"pmids\": [\"24390485\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether other kinases phosphorylate S33 in vivo\", \"How SUMOylation modulates wild-type FOXL2 transcriptional activity not detailed\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Conditional uterine deletion revealed FOXL2 functions beyond the ovary and pituitary, being required for uterine stromal and myometrial maturation and Wnt pathway regulation.\",\n      \"evidence\": \"Pgr-cre conditional KO with histology and expression profiling\",\n      \"pmids\": [\"25687138\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct FOXL2 binding sites in uterine cells not mapped\", \"Whether uterine defects contribute to infertility independently of ovarian failure not distinguished\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Genome-wide ChIP-seq in fetal ovary showing FOXL2 occupancy extensively overlapping SOX9 sites, combined with gain-of-function feminization of fetal testis, demonstrated that FOXL2 and SOX9 compete at shared regulatory elements to determine gonadal fate.\",\n      \"evidence\": \"ChIP-seq in fetal ovary, ectopic FOXL2 transgenic testis model, transcriptomics\",\n      \"pmids\": [\"30212841\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether FOXL2 and SOX9 physically compete for DNA occupancy or act through chromatin remodeling intermediaries not distinguished\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Discovery that RUNX1 acts redundantly with FOXL2 to maintain fetal granulosa identity — with overlapping chromatin occupancy — revealed that ovarian fate maintenance relies on a transcription factor network rather than FOXL2 alone.\",\n      \"evidence\": \"Double conditional KO causing fetal ovary masculinization, ChIP-seq overlap, single-cell transcriptomics\",\n      \"pmids\": [\"31712577\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether FOXL2 and RUNX1 form a physical complex or act independently at shared sites unknown\", \"Other transcription factors in the network not identified\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Mechanistic dissection of the C134W mutation showed it acquires neomorphic DNA-binding specificity, forms a novel complex with SMAD4/SMAD2/3 at hybrid motifs to activate an EMT-associated oncogenic program, while simultaneously being selectively degraded by a miR-1236/AGO3/DHX9 non-canonical miRISC to cause haploinsufficiency — together explaining both gain- and loss-of-function oncogenic mechanisms.\",\n      \"evidence\": \"ChIP-seq in isogenic WT vs. C134W lines and primary AGCT, CRISPR ablation of SMADs, co-IP, miRNA mutagenesis, AGO3/DHX9 co-IP, mouse AGCT model\",\n      \"pmids\": [\"32641411\", \"32641414\", \"33215742\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether pharmacological disruption of the FOXL2C134W-SMAD4 complex is therapeutically viable not tested\", \"How miR-1236 expression is regulated in AGCT unknown\", \"Structural basis of altered C134W DNA-binding specificity not resolved\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Lineage tracing of FOXL2-expressing cells revealed they are multipotent progenitors giving rise to granulosa, theca-interstitial, and stromal lineages, redefining FOXL2 from a granulosa-specific factor to a marker of a common ovarian somatic progenitor.\",\n      \"evidence\": \"Cre/Rosa lineage tracing and single-cell RNA-seq across developmental time points\",\n      \"pmids\": [\"36575161\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether FOXL2 is functionally required in theca and stromal differentiation or merely expressed\", \"Signals that direct FOXL2+ progenitors toward different lineages not identified\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the structural basis for C134W neomorphic DNA binding, the full enhancer-level logic by which FOXL2 coordinates with RUNX1 and other factors across ovarian cell types, and whether targeting the FOXL2C134W-SMAD4 axis is therapeutically tractable in granulosa cell tumors.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No crystal structure of FOXL2 forkhead domain bound to DNA\", \"Therapeutic targeting of FOXL2C134W-SMAD axis untested\", \"Single-cell-resolved FOXL2 function across all ovarian somatic lineages incomplete\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [4, 13, 14, 15, 22, 24, 25]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 3, 4, 5, 9, 13, 14, 15, 19, 22, 24, 25]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [2, 3, 4, 13, 22, 24, 25]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0074160\", \"supporting_discovery_ids\": [3, 4, 5, 9, 13, 14, 15, 22, 24, 25]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [4, 9, 12, 24]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [0, 1, 10, 22, 23, 30]},\n      {\"term_id\": \"R-HSA-1474165\", \"supporting_discovery_ids\": [8, 11, 12, 28]}\n    ],\n    \"complexes\": [\n      \"FOXL2-SMAD3 transcriptional complex\",\n      \"FOXL2-SMAD4-SMAD2/3 complex (C134W-specific)\",\n      \"FOXL2-SF-1 complex\"\n    ],\n    \"partners\": [\n      \"SMAD3\",\n      \"SMAD4\",\n      \"SMAD2\",\n      \"NR5A1\",\n      \"ESR1\",\n      \"PGR\",\n      \"RUNX1\",\n      \"SIRT1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}